G_genetic testing New recommendations from an international consensus conference call for genetic testing of all men with metastatic prostate cancer (PCa) and those with a family history indicative of ...

The Urology Care Foundation and the Prostate Cancer Foundation have created a new educational guide on genetic tests to guide ...

BOSTON--(BUSINESS WIRE)--Velsera, a global healthcare technology company offering a universal software platform to connect clinical care with discovery, and Solaris Health, the nation’s leading ...

P4 Diagnostix has teamed with Pierian, a company that provides an analysis platform, to launch somatic testing for patients with prostate cancer. The partnership will further develop P4 Diagnostix’s ...

Across all cancer types, less than 50% of patients underwent biomarker testing before first-line treatment. Many patients with advanced cancer do not receive guideline-recommended biomarker testing ...

MDxHealth has 4 validated testing products with one more in the clinical pipeline. All are focused specifically on urology. The company expects to do ~$65-$70M of sales in 2023, but the valuation is a ...

Clinical practice guidelines do not recommend routine PSA screening in men older than 75 years, men younger than 40 years, or men with a life expectancy of <10 years; however, inappropriate PSA ...

Amerinet, a national healthcare group purchasing organization, has announced it has signed an agreement with Mediwatch for urodynamics diagnostic equipment and urology/pelvic floor clinical testing ...